Royal Philips: From Medtech Supplier To Health Care Solutions Partner
CEO Frans van Houten On How To Build A Global Healthtech Player For The Future
Executive Summary
Health care delivery has been transformed over the past decade, and so has Royal Philips, whose CEO Frans van Houten explains why both were necessary, and the extra impetus for system-wide change following the COVID-19 pandemic.
You may also be interested in...
MHRA Offers Medtechs Extra Transition Time For UK Regulatory System Compliance
26 June saw the release finally of the UK government’s official response to the MHRA’s 2021 consultation on its post-Brexit medical devices regulatory framework. The considered response, held up by political and internal timing issues, represents an implementation plan for reform of the system. Crucially it allows industry extra compliance time.
NICE: Real-World Evidence Revolution Will Drive UK’s Health Care Innovation
In its just-released real-world evidence framework, NICE assesses the role and value of data collected outside highly-controlled clinical studies in driving more innovation towards health care professionals.
EU Medtech Industry Keeps Watchful Eye On Changing Needs In Ukraine
Ukraine’s medical supply needs have evolved since Russia launched its military invasion of the country on 24 February. EU healthcare decision makers and the medical technology industry have since stood firm in their support of the besieged country, said MedTech Europe’s Jesús Rueda.